PIC1 pre-clinical formulation and optimization as a novel anti-inflammatory pharmacological agent
Ended Project Grant Awarded Last action
- Award ID
- R44AI131764
- Recipient
-
Realta Life Sciences, Inc. UEI XMCANK57JBR6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,497,741
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Norfolk, VA 23507, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $578,570 | |
| Amendment | $0 | |
| Original award | $919,171 |
Quick answers
Who received award R44AI131764?
R44AI131764 was awarded to Realta Life Sciences, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 20, 2017.
How much is award R44AI131764 worth?
$1,497,741 has been obligated on R44AI131764.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award